ANTISERA TO HUMAN FRAGMENT— 510(k) K790711
Substantially EquivalentKent Laboratories, Inc.
FDA 510(k) clearance K790711 for ANTISERA TO HUMAN FRAGMENT, Substantially Equivalent on 1979-09-04. Applicant: Kent Laboratories, Inc.. Device class: 1.
Clearance details
- Applicant
- Kent Laboratories, Inc.
- Product code
- Code DFK
- Device class
- Class 1
- Regulation
- 21 CFR 866.5520
- Advisory panel
- Immunology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Mchenry, IL, US
Recent devices under product code DFK
view allMore clearances from Kent Laboratories, Inc.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.